Humana 1Q Revenue Rises on Higher Insurance Premiums, Membership Growth

Dow Jones
30 Apr
 

By Denny Jacob

 

Humana reported a rise in quarterly revenue as it benefited from higher premiums and membership growth for certain insurance lines.

The health-insurance company logged net income of $1.24 billion, or $10.30 a share, compared to $741 million, or $6.11 a share, in the prior-year period.

Stripping out one-time items, earnings came in at $11.58 a share. Analysts polled by FactSet expected $10.07 a share.

Revenue rose to $32.11 billion from $29.61 billion. Analysts polled by FactSet expected around $32.2 billion.

The Louisville, Ky., company attributed the year-over-year increase to its top line to higher per member Medicare and state-based contracts premiums, as well as membership growth in the company's Medicare standalone PDP and state-based contracts businesses.

Humana maintained its guidance for fiscal 2025 but revised its earnings per-share estimate to now be around $14.68, down from a prior forecast around $15.88.

Huamana affirmed its expectation that individual Medicare Advantage annual memberships will decline about 550,000, inclusive of the impact of exiting certain unprofitable plans and counties.

"Medicare Advantage is performing as expected and we are excited about our progress in expanding CenterWell and Medicaid," said CEO Jim Rechtin.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

April 30, 2025 07:23 ET (11:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10